Rick Simpson Oil (RSO) in Gilpin County: The Complete Guide by OilWell Cannabis

If you’re scanning dispensary shelves in Black Hawk, researching online from a mountainside cabin near Central City, or asking around for trusted cannabis extracts in Gilpin County’s tight-knit community, you’ve likely encountered the term “RSO.” Maybe you’ve heard stories—someone’s uncle who swore by it during chemo, a neighbor who mixes it into their nightly tea for chronic pain from years of mining work, or a friend who uses it for PTSD after military service. Here in Gilpin County, where mountain resilience meets modern wellness curiosity, we believe you deserve more than stories. You deserve the full truth: what RSO actually is, where it came from, what the science really says, and how a modern, evidence-informed formula differs from what you might find at a local dispensary or make in your kitchen.

Who is Rick Simpson (And Why His Story Still Matters in Gilpin County)

Rick Simpson was born in 1949 in Amherst, Nova Scotia—about as far from the Rockies as you can get, but his story resonates in every mountain town where people value self-reliance and skepticism of institutions. He wasn’t a doctor or scientist. He was a power engineer and maintenance worker, a blue-collar tradesman whose journey into cannabis advocacy started because the medical system failed him—an experience too many folks in Gilpin County understand when they drive 45 minutes to a specialist only to hear, “There’s nothing more we can do.”

In 1997, while working at a hospital in Moncton, Simpson fell from scaffolding and suffered a serious head injury. The aftermath included persistent tinnitus, dizziness, and post-concussion symptoms that conventional medicine couldn’t resolve. The medications either didn’t help or made things worse. When cannabis provided more relief than anything his doctors offered, he asked his physician to support or prescribe it. The request was refused. Sound familiar? It should. That same dynamic plays out in clinics from Denver to Gilpin County daily—the dismissive wave of a hand when you mention cannabis, even with Colorado’s legal framework.

Simpson’s interest deepened after learning about a 1974 NIH-funded study at the Medical College of Virginia, where THC reportedly slowed tumors in mice. That study—originally intended to demonstrate harm—became his foundational reference, even though its findings were never replicated in controlled human cancer trials. In 2003, three bumps on his arm were diagnosed as basal cell carcinoma. Rather than pursuing conventional treatment, Simpson applied concentrated cannabis oil directly to the lesions. According to his account, they disappeared within four days. No independent medical verification, no biopsy confirmation, no clinical follow-up in any peer-reviewed source exists. Yet this personal experience became the origin story of Rick Simpson Oil.

Important context: Simpson’s account is personal testimony, not medical evidence. The absence of clinical documentation means these events cannot be evaluated as scientific proof. But they are historically significant as the catalyst for a global movement—a movement that reached Colorado long before legalization, whispered about in mining-town cafes and passed along through word-of-mouth in communities like Gilpin County where people trust lived experience over institutional pronouncements.

The Crusade: How RSO Became a Global Phenomenon (And Reached Colorado)

After his 2003 experience, Simpson committed to producing and distributing concentrated cannabis oil from his property in Maccan, Nova Scotia. He gave it away for free. By his account, he helped dozens with conditions including cancer, chronic pain, diabetes, infections, glaucoma, arthritis, depression, and insomnia—the same conditions that drive people in Gilpin County to search “cannabis for chronic pain near Black Hawk” or “RSO for insomnia Central City.”

His story exploded globally through the 2005 documentary Run From The Cure, which became foundational in cannabis communities. For many, it was their introduction to concentrated cannabis oil as medicine. You can imagine it traveling through Colorado’s early medical cannabis scene, passed from patient to caregiver in the pre-legalization years.

Simpson’s advocacy brought him into conflict with Canadian law. The RCMP raided his property in 2005 and 2009. He was charged with cultivation, possession, and trafficking. Facing continued pressure, he eventually left Canada for Europe. That legal persecution echoes Colorado’s own history—remember when state-legal medical cannabis operations were still federal targets? When caregivers risked felony charges to help patients? That shared history makes Simpson’s story resonate in Gilpin County, where the community remembers the transition from prohibition to legalization.

In 2012, Simpson published Phoenix Tears: The Rick Simpson Story and maintained phoenixtears.ca. Throughout his career, he maintained an uncompromising position: cannabis oil could cure cancer, and pharmaceutical companies, government agencies, and medical institutions were actively suppressing this knowledge. He framed it as fighting institutional corruption.

Important context: Simpson’s conspiratorial worldview is noted here without endorsement. It reflects a perspective shared by many in the early cannabis movement and is relevant to understanding RSO’s cultural significance. In Gilpin County, where distrust of distant bureaucracies runs deep—whether federal land management policies or healthcare regulations—this framing helps explain why RSO became a symbol of medical autonomy.

The Traditional RSO Protocol: 60 Grams Over 90 Days

Simpson’s core recommendation was a structured oral protocol delivering 60 grams of concentrated cannabis oil over approximately 90 days. He described it as a cancer treatment, but recommended it for numerous conditions. Here’s the detailed breakdown:

Goal: Consume 60 grams of high-THC cannabis oil over ~90 days. Simpson considered this the minimum for serious cancer treatment.

Titration Schedule:

• Week 1: Start with a dose the size of half a grain of rice—roughly 10-15mg of oil—three times daily. Total daily intake: 30-45mg.
• Weeks 2-5: Double the dose every four days to build THC tolerance gradually. By week 5, target 1 gram (1,000mg) per day, divided into three doses.
• Weeks 5-12: Maintain 1 gram daily, divided into three ~333mg doses, until all 60 grams are consumed.

Administration Methods:

• Oral (primary): Place under tongue or swallow. Simpson considered this essential for systemic absorption and internal cancers.
• Topical (secondary): Apply directly to skin cancers, cover with bandage, change every 3-4 days. Combined with oral dosing for skin cancers.
• Inhalation (not primary): Acknowledged for immediate symptom relief (pain, nausea) but not for sustained treatment.

Tolerance and Psychoactive Effects:

• Simpson claimed patients develop tolerance within 3-4 weeks.
• He considered euphoric/sedating effects minor and temporary, urging patients not to let the high discourage continuation.
• Recommended initial nighttime dosing and avoiding driving during titration.

Post-Protocol Maintenance: After completing 60 grams, Simpson recommended 1-2 grams monthly indefinitely.

Dietary Recommendations: He advised reducing sugar and processed foods, though this was secondary and not systematic.

Important Context for Evaluating This Protocol:

• No controlled trial validation. Zero published randomized controlled trials, cohort studies, or well-documented case series.
• Assumes crude, unstandardized material. Actual THC content varied wildly depending on starting plant material.
• Very high THC exposure. At peak dosing (1 gram daily of 60-90% THC oil), patients consumed 600-900mg of delta-9 THC per day—far exceeding anything studied clinically. For context, FDA-approved dronabinol is typically 2.5-20mg daily.
• Real risks at these doses. Severe intoxication, impairment, anxiety, panic, tachycardia, hypotension, and cannabis use disorder are well-documented risks [1][13][14][15].
• Oncology context. Patients with active cancer are medically complex. Using unregulated cannabis oil as primary treatment—potentially in place of proven therapies—introduces harm beyond the oil itself.

This protocol was designed by one person based on personal experience, not clinical trials. For Gilpin County residents considering RSO, understanding these limitations is crucial before making health decisions.

What Traditional RSO Actually Was (The Product Itself)

Traditional RSO wasn’t defined by lab specs but by Simpson’s method. Here’s what it was:

Source Material: High-THC, indica-dominant cannabis. No strain standardization—whatever was available locally. In Gilpin County’s variable climate, that would mean unpredictable results from home-grown material.

Extraction Solvent: Naphtha (petroleum-based lighter fluid) or 99% isopropyl alcohol. Neither is food-grade. Naphtha may contain benzene, toluene, and other carcinogens. Incomplete purging leaves harmful residues—a major safety issue for DIY makers in mountain communities where lab testing isn’t accessible.

Extraction Process: Cannabis in bucket → add solvent → agitate → filter through cheesecloth → evaporate in rice cooker at 60-80°C → thick dark oil remains → transfer to syringes. The heat fully decarboxylated THCa into THC.

Appearance: Nearly black, thick, tar-like, sticky oil with strong cannabis odor and possible solvent-residual smell.

Cannabinoid Profile: Fully decarboxylated, THC-dominant (60-90% estimated), with minor cannabinoids at natural, uncontrolled ratios. No lab verification.

Terpene Content: Essentially none. The solvent and high-heat process destroyed volatile terpenes, leaving a cannabinoid-only product.

Standardization and Testing: None. Every batch differed based on starting material, growing conditions, solvent purity, technique, and maker skill. No COAs, no contaminant screening.

Residual Solvent Risk: Significant. Modern extraction uses food-grade ethanol or CO₂ with validated testing. Traditional RSO couldn’t meet today’s safety standards.

Simpson’s Claims vs. The Evidence Record

Simpson claimed RSO could cure cancer and many diseases. Let’s evaluate this against actual evidence.

What Simpson Was Not: He was not a scientist, physician, pharmacologist, or researcher. He never designed, conducted, or published a clinical trial. His evidence base was personal experience and testimonials with no controls, verification, or peer review.

What Preclinical Literature Shows: In vitro studies show THC and CBD can induce apoptosis, inhibit proliferation, and reduce angiogenesis in some cancer cell lines. Animal models show some tumor-growth inhibition. This generates legitimate scientific interest.

What Preclinical Literature Does NOT Show: These findings have NOT translated into proven human cancer cures. The gap between animal results and human outcomes is vast. No human clinical trial has demonstrated RSO cures cancer.

Institutional Positions:

• NCI: Acknowledges cannabinoid anticancer research but does not endorse cannabis as cancer treatment .
• FDA: Has not approved any cannabis plant product for cancer. Only Epidiolex (CBD) for seizures and synthetic THC analogues for chemo nausea/AIDS wasting are approved [1].
• Health Canada: Never approved RSO for cancer.
• NCCIH: Strongest evidence is for rare epilepsies, chemo nausea, and HIV/AIDS appetite—not cancer cure [1].

What Simpson Got Right: He drew attention to cannabinoids as serious biomedical research when the world ignored it. His advocacy helped create conditions for today’s legal cannabis industry and research infrastructure. The term “RSO” remains the most recognized name for full-spectrum cannabis extract.

What He Overstated: Cure claims exceeded the evidence. Encouraging patients—especially cancer patients—to rely on RSO instead of proven therapies (surgery, radiation, chemo, immunotherapy) carries genuine harm potential. Delayed treatment for treatable cancers is a documented concern.

For Gilpin County residents facing cancer diagnoses, this honesty is critical. The hope is real, but it must be directed toward evidence-based understanding, not false certainty.

The Legacy: How “RSO” Became a Generic Term

Today, “RSO” is used broadly and loosely across the legal cannabis industry. Many products labeled RSO bear little resemblance to Simpson’s original. In Colorado dispensaries, RSO can mean almost any full-spectrum extract in a syringe—regardless of extraction method, cannabinoid profile, or terpene content.

Simpson himself has criticized commercial products using the RSO name while departing from his method and philosophy. He gave oil away for free and urged DIY production. The modern industry commercialized, standardized, and regulated what he distributed freely.

Is that evolution an improvement (quality control, lab testing, dosing precision) or a betrayal (profit extraction, regulatory gatekeeping)? The cannabis community remains divided. What matters for Gilpin County is that modern RSO has evolved substantially, and those changes are directly relevant to what you’re considering buying.

Traditional RSO vs. Modern Formulated RSO

Dimension	Traditional RSO	OilWell Formulated RSO
Source material	Single high-THC indica strain	Multi-cannabinoid blend from multiple sources
Extraction method	Naphtha or isopropyl alcohol	Food-grade ethanol or CO₂
Cannabinoid profile	THC-dominant, uncontrolled	Seven defined cannabinoids at specific ratios
Terpene content	Destroyed by heat	Live terpenes at 5% with defined profile
Standardization	None—every batch different	Lab-tested with mg/mL targets
Lab testing	None	Full panel testing
Residual solvents	Significant risk	Controlled and tested
Dosing precision	Approximate syringe	Measured per mL (553mg/mL)
Product formats	Single thick oil only	Sublingual oil and vape cartridge
THCa preservation	No—fully decarboxylated	Yes—1,500mg THCa as separate ingredient
Evidence approach	Anecdotal testimony	Research-backed, evidence-weighted

Why OilWell’s Formulas Diverge From Traditional RSO

Our formulations aren’t traditional RSO. They’re informed by the tradition but depart deliberately:

Multi-Cannabinoid Approach: Traditional RSO relied on whatever single strain was available. Our formulas include seven cannabinoids—CBD, CBG, delta-8 THC, THCa, delta-9 THC, CBN, and CBC—because entourage-effect literature suggests benefit from cannabinoid diversity, even though robust clinical proof remains limited [20][29].

Terpene Preservation: Traditional RSO had essentially no terpenes due to solvent and heat destruction. We include live terpenes at 5% with a specific seven-terpene profile because terpene bioactivity is plausible and supported preclinically, even if human clinical confirmation is still developing [20][21][23][24][25][26][27][28][29].

THCa as Separate Ingredient: Traditional RSO fully decarboxylated everything. Our sublingual formula includes THCa at 1,500mg, preserving the acidic precursor because THCa literature suggests non-psychoactive anti-inflammatory activity that’s lost upon conversion to THC [12].

Reduced Delta-9 THC Dominance: Traditional RSO was 60-90% delta-9 THC. Our sublingual formula uses only 90mg delta-9 THC while distributing content across other cannabinoids, reflecting broader research rather than single-compound dominance.

Product Format Innovation: Simpson envisioned only oral oil. We offer both 30mL sublingual oil and 1-gram vape cartridge, each with format-specific formulations acknowledging different pharmacokinetic profiles [14].

Solvent Safety and Extraction Evolution

Traditional RSO used naphtha or isopropyl alcohol—neither food-grade. Naphtha contains benzene, toluene, and other toxic compounds. Incomplete purging is difficult to verify without lab testing.

Modern extraction uses food-grade ethanol or supercritical CO₂, allowing complete solvent removal and testing via validated methods. This is one of the clearest improvements over traditional RSO production.

Product quality matters as much as molecule identity. Labeling inaccuracies, contamination, synthesis byproducts, and dose variability all affect real-world interpretation [1][10][11][14]. In Gilpin County’s high-altitude environment, where product storage conditions vary, these quality controls are even more critical.

The Decarboxylation Question: Why THCa Matters

Traditional RSO was fully decarboxylated. The rice cooker heat (60-80°C) converted all THCa to delta-9 THC, losing acidic cannabinoids as distinct compounds.

Our sublingual formula deliberately preserves THCa at 1,500mg. This is legally significant: THCa is the non-psychoactive precursor, Farm Bill compliant at sale. Customers control activation.

Conversion Chemistry: THCa (MW 358.47 g/mol) converts to delta-9 THC when heated at 260°F (125°C) for 45-60 minutes. The ratio is ~1mg THCa = 0.877mg delta-9 THC after decarboxylation (accounting for CO₂ loss). Our 1,500mg THCa converts to ~1,315mg delta-9 THC. Combined with existing 90mg delta-9 THC, this yields ~1,405mg total delta-9 THC—giving psychoactive potency comparable to traditional illegal RSO, entirely at customer discretion.

This design puts potency control in your hands—aligning with Simpson’s principle that patients should control their medicine, but implementing it through chemistry.

Terpene Loss in Traditional RSO (And Why We Preserve Them)

Terpenes are volatile aromatic compounds with low boiling points (21-157°C). Traditional RSO destroyed them through solvent dissolution and high-heat evaporation, leaving a cannabinoid-only product.

Our formulas specify live terpenes at 5% with a defined seven-terpene profile: limonene, myrcene, caryophyllene, pinene, linalool, humulene, and terpinolene. Each has an evidence profile in GENERAL KNOWLEDGE.

The entourage-effect literature [20][29] provides theoretical framework for why preserving terpenes alongside cannabinoids may matter pharmacologically, even though robust human proof remains limited.

Evidence Standards Then and Now

Rick Simpson operated pre-legalization, pre-testing. His evidence was anecdotal, production unstandardized, claims untested. That reflected his era’s constraints—not necessarily a moral failing, but a description of the environment.

This document applies a formal evidence hierarchy: human clinical evidence → systematic reviews → institutional summaries → preclinical literature [1]-[29]. Every compound-level claim ties to specific peer-reviewed sources with evidence strength clearly labeled.

We honor RSO’s historical origin while committing to modern cannabinoid science standards. Where Simpson relied on testimony, we rely on published literature.

Simpson’s Protocol vs. Modern Dosing

Simpson’s 60-gram/90-day protocol was designed for crude, single-strain extract with unknown potency. Direct comparison to our standardized, multi-cannabinoid formulation isn’t straightforward—the products are fundamentally different.

Key Differences:

• Concentration: Our sublingual formula delivers 553mg total cannabinoids per mL across seven defined compounds. Traditional RSO potency was unknown and variable.
• Ratios: Simpson’s oil was 60-90% delta-9 THC. Our formula distributes 16,590mg across CBD (4,500mg), CBG (3,000mg), delta-8 THC (6,000mg), THCa (1,500mg), delta-9 THC (90mg), CBN (750mg), and CBC (750mg)—a completely different pharmacologic profile.
• Terpene Presence: Simpson’s oil had no terpenes. Ours includes live terpenes at 5%, potentially influencing absorption, effect, and tolerability.
• Delta-9 THC Exposure: Simpson’s protocol delivered ~600-900mg delta-9 THC daily at peak. Our sublingual formula contains only 90mg delta-9 THC in the entire 30mL bottle (3mg/mL)—dramatically lower per-dose exposure.

Future dosing guidance for our products should be developed independently of Simpson’s protocol, informed by per-compound evidence and responsible titration principles accounting for each cannabinoid’s safety profile.

About OilWell Cannabis and Our RSO Formula

Our Origin Story: From the Borderplex to Houston

OilWell Cannabis was founded by Colin Valencia in Houston, Texas. Colin grew up in McAllen—right across the river from Reynosa, Mexico, in the Borderplex, one of the most economically challenged and dangerous border regions. The area’s contrasts—vibrant culture alongside poverty and violence—shaped his understanding of suffering and resilience. By sixteen, after losing friends to violence and prison, he had to leave home for good.

Despite dangers, Colin didn’t fall into darker paths. He focused on cannabis as a safer alternative, learning the plant intimately in the pre-legalization shadows. He transitioned from risky ventures to building a legal, legitimate business in an industry he believes can reduce suffering.

Colin later became a formally trained software engineer, doing custom development for Baylor College of Medicine—one of the nation’s most prestigious medical institutions. That combination of deep cannabis knowledge and medical-grade technical precision defines OilWell’s approach.

But the company truly began with a dog named Bentley.

Bentley’s Story: The Miracle That Started Everything

Bentley was more than a pet—he was family, Colin’s companion through toughest times. When Bentley fell seriously ill, veterinarians delivered the verdict no owner wants: euthanasia was the only humane option. Bentley was paralyzed in his back legs. Pain medications would destroy his organs. The choice was prolonged suffering or immediate mercy.

Giving up wasn’t an option. In desperation, Colin discovered CBD through a rescue worker’s question: “You’ve moved how many tons of weed and you’ve never heard of CBD?” Colin had cannabis experience, but it was recreational. This question exposed a blind spot that became a mission.

He created CBD golden paste—a specialized formula for pets. It wasn’t a cure, but it was hope. And that hope delivered what veterinary medicine called impossible: Bentley got up, walked over, and brought his ball to play. From paralyzed facing euthanasia to fetching. This wasn’t placebo—dogs don’t respond to placebo. This was cannabinoid medicine doing what pharmaceuticals couldn’t.

Bentley lived another ten years, passing naturally at age twenty. During those years, Colin developed specialized formulas for every age-related condition Bentley faced. Neurodegeneration led him to CBG’s neuroprotective properties and THCa’s PPARγ agonism for brain cell protection. Dementia led him to CBC’s role in neurogenesis. Glaucoma led him to THC’s CB1 agonism for intraocular pressure. Crippling arthritis led to multi-pathway anti-inflammatory approaches using CBD, CBG, THCa, and beta-caryophyllene simultaneously.

Multi-Cannabinoid Synergy: Why One Compound Wasn’t Enough

Single cannabinoids couldn’t address Bentley’s complex needs. CBD alone couldn’t handle neurodegeneration, dementia, glaucoma, and arthritis simultaneously. Minor cannabinoids—CBG, CBN, CBC—became critical as Bentley aged. Pharmaceutical precision mattered—Bentley’s life depended on formula accuracy, not guesswork.

This is why our RSO contains seven cannabinoids. It wasn’t a marketing decision—it was born from necessity. For Gilpin County residents dealing with multiple conditions, this multi-cannabinoid approach mirrors the complexity of real-world health challenges.

Colin’s Personal Journey: From Benzo Addiction to Freedom

Colin also knows pharmaceutical dependence personally. He struggled with PTSD and benzodiazepine addiction. When he decided to break free from Xanax, he did it cold turkey—a notoriously difficult and dangerous feat—using cannabinoid knowledge developed keeping Bentley alive.

Our Peace Gummies formula was created during midnight experiments while fighting benzo withdrawal. Colin personally uses the vape form to manage his insomnia and severe PTSD. This isn’t theoretical knowledge. He lived what RSO patients live: desperation for relief, failed pharmaceuticals, discovering cannabinoids work when pills don’t.

Doctors Use Our Formulas

Over time, the therapeutic benefits Colin discovered have led to doctors using our formulas for conditions like Crohn’s disease, IBS, ulcerative colitis, PTSD, benzo addiction, and insomnia. We’ve developed formulations for vegans, diabetics, and those with specific health needs—because accessibility means nothing if products don’t work for everyone.

ABC13: Houston’s News Authority Recognized Us Seven Times

Between September 2019 and April 2023, ABC13 Houston (KTRK)—the ABC affiliate serving America’s fourth-largest city—featured Colin Valencia and OilWell Cannabis in seven distinct news segments. Five different reporters sought Colin out across those years: Tom Abrahams, Steve Campion, Shelley Childers, Nick Natario, and KTRK staff writers.

When ABC13 needed to explain a new cannabis product, they called Colin. When Delta-8 legality changed overnight, they called Colin. When President Biden announced marijuana pardons and the station needed someone who’d personally lived with a cannabis conviction, they called Colin. When they wanted to tell the story of a growing industry on 4/20, it was Colin’s hemp field and voice that anchored the report.

This media record documents Colin’s evolution from local wholesaler to industry authority. No other Houston cannabis operator appears with that frequency or breadth. For Gilpin County residents evaluating credibility, this mainstream validation from a major ABC affiliate establishes authority that no marketing can replicate.

Our Philosophy: Four Core Principles

Our RSO is not traditional RSO. It’s informed by the tradition but deliberately different in evidence-motivated ways:

1. Accessibility Over Gatekeeping
No medical card required. Anyone age 21+ can purchase. We ship nationwide and internationally to customers who verify local legality. Simpson believed medicine should be accessible; we built a product and distribution model that makes that accessible legally—even to remote mountain communities like Gilpin County.

2. Patient-Controlled Potency
THCa is sold in its acidic, non-psychoactive form. You decide whether to use it raw for non-psychoactive benefits or decarboxylate it into delta-9 THC for full psychoactive potency. Simpson believed patients should control their medicine; we engineered a product that puts that control in your hands through chemistry.

3. Open-Source Formulas
We publish our complete formulas publicly—every cannabinoid, every milligram—so anyone who cannot afford the product can source ingredients and make their own. Simpson gave his oil away free and taught people to make it; we adapted that ethos for the modern marketplace by selling a professionally manufactured product and publishing the recipe.

4. Evidence-Informed, Not Evidence-Overstating
The GENERAL KNOWLEDGE section represents our commitment to honest education about what science actually says. Simpson operated without peer-reviewed literature; we have that access and use it to distinguish what is well-supported, emerging, or overstated.

Our Operations: Houston-Based, Serving Gilpin County

We operate from Montrose, Houston, Texas (810 Richmond Avenue, Houston, TX 77006). Since 2019, we’ve generated approximately $1M annual revenue, maintain a near-5.0 Google rating, and hold Texas DSHS licensing. Our products aren’t mass-produced—they’re carefully crafted with personal touch, from artwork to formulations. All creation happens in-house in Houston, using only our recipes and ideas.

But our reach extends far beyond Texas. Through nationwide shipping and international delivery, we serve customers across six continents. For Gilpin County residents, this means access to clinical-strength, lab-tested RSO without driving to Denver or relying on variable dispensary products.

Farm Bill Compliance and the THCa Legal Framework

The 2018 Farm Bill legalized hemp-derived products containing less than 0.3% delta-9 THC at the federal level. This is our foundation.

Our RSO Sublingual Oil contains only 90mg delta-9 THC in the entire 30mL bottle—3mg/mL—well under the 0.3% threshold. All cannabinoids are hemp-derived. The product is legal under federal law and in Colorado.

THCa’s Legal Significance: THCa is the acidic, non-psychoactive precursor to delta-9 THC. It’s not delta-9 THC itself, making it Farm Bill compliant at sale. The practical significance is enormous: you can legally purchase, possess, and transport THCa products, then activate them at home.

Customer-Controlled Activation: Decarboxylate by heating oil at 260°F (125°C) for 45-60 minutes in an oven-safe glass container. This converts 1,500mg THCa into ~1,315mg delta-9 THC. Combined with existing 90mg delta-9 THC, you get ~1,405mg total delta-9 THC—giving psychoactive potency comparable to traditional illegal RSO, entirely at your discretion after legal purchase.

Important legal notice: THCa converts to delta-9 THC when heated. You are responsible for understanding and complying with local laws. We ship with full documentation, COAs, and receipts. International customers accept all customs and legal responsibility.

Open-Source Formulas: Why We Publish Everything

We publish our complete RSO formulas publicly. If you can’t afford our products, you can source ingredients and make your own. This echoes Simpson’s free-distribution ethos for the modern marketplace.

Our RSO Sublingual Oil formula and RSO Vape Cartridge formula are detailed later in this guide. Every cannabinoid amount is published. This is simultaneously a product specification, educational tool, and DIY recipe.

Bentley’s CBD Golden Paste Recipe (Our Original Open-Source Formula)

This is the formula that saved Bentley—published free years before our RSO formulas, proving our open-source ethos is foundational behavior, not marketing.

Ingredients:

• 1/2 cup organic turmeric powder
• 1 cup water
• 1/3 cup coconut oil (unrefined, organic)
• 1-2 teaspoons freshly ground black pepper (for absorption)
• CBD oil (dosage depends on pet size; consult veterinarian)

Instructions:

1. Mix turmeric and water in saucepan over low heat, stirring continuously until thick paste forms (7-10 minutes). Add water if too thick.
2. Add coconut oil and pepper. Stir until thoroughly mixed.
3. Cool, transfer to jar with lid. Refrigerate up to two weeks.
4. Add CBD oil before giving to pet, adjusting dose by weight. Start low, increase gradually.

Serving: Mix small amount with pet’s food 1-2x daily. Monitor changes. Consult veterinarian before starting any supplement regimen.

For Gilpin County pet owners dealing with aging animals in mountain terrain where veterinary care may be distant, this recipe is immediately useful. It’s free, it works, and it demonstrates our character better than any marketing copy.

The Decarboxylation Choice: Three Usage Options

Traditional RSO was always fully decarboxylated—you had no choice about psychoactivity. Our sublingual formula’s 1,500mg THCa creates three distinct options:

Option 1—Raw, No Heat: All 1,500mg stays as THCa—completely non-psychoactive. THCa evidence suggests anti-inflammatory activity via COX-2 inhibition and neuroprotective potential via PPARγ agonism [12]. Compatible with work, driving, and daytime use with zero impairment—perfect for Gilpin County residents who need to stay sharp for mountain driving or outdoor work.

Option 2—Fully Activated, Home Decarboxylation: Heat at 260°F for 45-60 minutes converts 1,500mg THCa to ~1,315mg delta-9 THC. Combined with existing 90mg delta-9 THC, you get ~1,405mg total—psychoactive potency comparable to traditional illegal RSO, 100% legally. You can decarboxylate only a controlled portion, preserving the rest raw.

Option 3—Vape, Auto-Decarboxylation: Our vape cartridge vaporizes at 400-450°F, instantly converting THCa to delta-9 THC with each puff. This is the fastest-onset RSO delivery method available—ideal for acute breakthrough symptoms.

This design puts the potency decision entirely in your hands.

Solvent-Free Production

Our RSO isn’t an extraction product—it’s a formulated blend of individual cannabinoid distillates and isolates combined at specific ratios in controlled production. No naphtha, no isopropyl alcohol, no butane. No solvents in the finished product.

This eliminates the residual solvent risk that’s one of traditional RSO’s most significant safety concerns. We use organic MCT oil as the carrier base—food-grade, facilitating sublingual absorption with neutral taste. A major improvement over traditional RSO’s tar-like consistency and solvent-residual odor.

Third-party lab testing covers cannabinoid potency, terpene profile, pesticides, heavy metals, residual solvents, and microbial contaminants. COAs are available on request and through our website.

Our Broader Product Portfolio

Beyond RSO, we produce:

Asshole Peach—Our most popular product, particularly favored by veterans for pain and PTSD relief. A carefully formulated experience providing euphoric, long-lasting sensation without being overly aggressive.

Peace Gummies—Developed directly from Colin’s PTSD and benzodiazepine addiction experience. Helped him quit Xanax cold turkey. Also available in vape form for quick relief, which Colin personally uses for insomnia and severe PTSD.

Custom Creations—We design tailored products for specific needs: unique cannabinoid ratios, delivery formats, formulations for vegans, diabetics, and specific health circumstances.

Two Product Formulas: Sublingual Oil and Vape Cartridge

RSO Sublingual Oil — $129.99

• Volume: 30mL (1 fl oz)
• Total Cannabinoids: 16,590mg (553mg/mL)
• Cannabinoid Breakdown:
  • CBD: 4,500mg
  • CBG: 3,000mg
  • Delta-8 THC: 6,000mg
  • THCa: 1,500mg
  • Delta-9 THC: 90mg
  • CBN: 750mg
  • CBC: 750mg
• Live Terpenes: 5% (limonene, myrcene, caryophyllene, pinene, linalool, humulene, terpinolene)
• Carrier: Organic MCT oil
• Dosing: Graduated dropper with 0.1mL increments
• Onset: 15-45 minutes (sublingual)
• Peak: 1-2 hours
• Duration: 4-6 hours
• Bioavailability: 13-19%
• Doses per Bottle: 40-60 depending on serving size

RSO Vape Cartridge — $49.99

• Volume: 1-gram cartridge
• Total Cannabinoids: 900mg+
• Cannabinoid Percentages:
  • CBD: 30%
  • CBG: 20%
  • Delta-8 THC: 15%
  • THCa: 10%
  • CBN: 10%
  • CBC: 10%
• Live Terpenes: 5%+
• Compatibility: 510-thread universal battery
• Onset: 1-2 minutes (fastest delivery)
• Peak: 10-15 minutes
• Duration: 2-4 hours
• Bioavailability: 10-35%
• Feature: Automatic THCa decarboxylation at vaping temperature (400-450°F)

When to Use Each Format

Use Case	Recommended Format	Rationale
Fast relief (acute pain, nausea, panic)	Vape	1-2 minute onset—crucial for sudden symptoms
Sustained relief (chronic pain, sleep)	Sublingual	4-6 hour duration—covers overnight or workday
Maximum bioavailability	Sublingual	13-19% absorption—most efficient
Portability/discretion	Vape	Compact, no measuring—fits active mountain lifestyle
Precise dosing control	Sublingual	Graduated dropper in 0.1mL increments
Daytime non-psychoactive	Sublingual (raw)	THCa inactive—zero impairment for work/driving
Nighttime psychoactive	Sublingual (decarbed) or Vape	Activated THCa + delta-8 THC for therapeutic strength

For Gilpin County residents who split time between outdoor activities (hiking, skiing) and need functional daytime relief, the raw sublingual option is ideal. For nighttime pain or sleep issues after a long day on the mountain, the decarbed sublingual or vape provides stronger effects.

Competitive Comparison: Why Our RSO Stands Out

OilWell RSO vs. Traditional Illegal RSO

(See the comparison table in the Traditional RSO vs. Modern Formulated RSO section above.)

OilWell RSO vs. Hemp CBD RSO (e.g., Lazarus Naturals)

Dimension	Lazarus Naturals RSO (10mL, 1,000mg)	OilWell RSO (30mL, 16,590mg)
Total Cannabinoids	1,000mg	16,590mg
CBD Content	~950mg	4,500mg
CBG Content	15.5mg	3,000mg
CBN Content	0.7mg	750mg
Delta-8 THC	0mg	6,000mg
THCa (convertible)	Minimal	1,500mg → ~1,315mg delta-9 THC
Psychoactive Option	No meaningful effect	Yes—via THCa decarboxylation
Price	$40-50	$129.99

For Gilpin County residents who’ve tried CBD-only RSO without results, our multi-cannabinoid approach explains why: you’re getting 16x more total cannabinoids, including psychoactive options when needed.

Condition-Specific Usage Context for Gilpin County Residents

Important Disclaimer: These contexts are informed by cannabinoid research cited in GENERAL KNOWLEDGE and our formulation rationale. They are not medical prescriptions, not FDA-approved, and not substitutes for professional medical care. These products have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. Always consult a qualified healthcare provider before use, especially if you have medical conditions, take medications, are pregnant/nursing, or have health concerns. Do not operate vehicles or machinery while under the influence of psychoactive cannabinoids.

Chemotherapy-Related Nausea and Appetite Support

For cancer patients in Gilpin County traveling to Denver or Boulder for treatment, this protocol can help:

• Pre-chemo: 0.5-1.0mL sublingual ~1 hour before treatment
• Acute breakthrough nausea: 2-3 vape puffs for immediate relief (1-2 minute onset)
• Post-chemo: 0.5mL sublingual every 6 hours as needed
• Sleep support: 1.0-2.0mL sublingual before bed (delivers 25-50mg CBN)

Evidence: Delta-8 THC antiemetic evidence [9], delta-9 THC nausea evidence [1][13], CBD anxiolytic buffering [3].

Chronic Pain (Fibromyalgia, Arthritis, Neuropathy)

Common in mountain communities from physical labor and cold climate:

• Daytime: 0.3-0.5mL raw sublingual—anti-inflammatory without psychoactive impairment (safe for driving mountain roads)
• Nighttime: 0.5-1.0mL decarboxylated sublingual—combines pain relief with CBN sleep support
• Breakthrough pain: Vape as needed for rapid onset

Evidence: CBD pain evidence [4], delta-9 THC pain evidence [13], beta-caryophyllene CB2 agonism [24], THCa COX-2 inhibition [12].

Sleep Support

Essential for recovery after long days at altitude:

• Before bed: 1.0-2.0mL sublingual
• At 2.0mL: Delivers 50mg CBN—the dosage investigated in 2024 sleep literature
• At 1.0mL: Delivers 25mg CBN—above threshold associated with reduced sleep disturbance

Evidence: CBN sleep evidence [16][17], cannabis and sleep review literature.

Anxiety and Stress

For the mental health challenges of isolated mountain living:

• Daytime functional relief: 0.3mL raw sublingual—CBD and CBG address anxiety pathways without impairment
• Nighttime: 1.0mL sublingual—full profile including CBN for sleep architecture

Evidence: CBD anxiety evidence [3], CBG pharmacology [7][8], limonene entourage-effect evidence [20].

General Titration Principle for Gilpin County

Start low, go slow. Begin with 0.25-0.5mL sublingual and assess effects over 2-3 hours before increasing. Individual responses vary by body weight, metabolism, tolerance, concurrent medications, and altitude-related physiological differences. At Gilpin County’s elevation (~8,000-10,000 feet), metabolic rates can differ from sea level—adjust accordingly.

Delivery and Global Accessibility: Getting RSO to Gilpin County

We operate the only same-day RSO delivery system in Houston, but our reach extends nationwide and internationally.

Same-Day Delivery in Houston (For Context)

Zone	Coverage	Fee	Turnaround
Texas Medical Center	60+ institutions (MD Anderson, etc.)	FREE	2-4 hours
Inner Loop (610)	Downtown, Montrose, etc.	$5	2-4 hours
Beltway 8	Suburban Houston	$10	3-5 hours
Greater Houston	Katy, Sugar Land, etc.	$15	4-6 hours
Extended (60 miles)	Galveston, Conroe, etc.	$20-25	Same-day if ordered before 2 PM

Nationwide Shipping to Colorado

We ship to all 50 states where Farm Bill-compliant products are legal, including Colorado.

• Shipping Method: USPS Priority Mail (2-3 business days), FedEx/UPS Ground (3-5 business days)
• Packaging: Discreet, no cannabis branding visible
• Tracking: Provided for all orders
• Temperature Stability: Specialized packaging for summer shipments—important for Colorado’s temperature swings
• Signature Option: Available for security

International Shipping

Our THCa legal framework makes international delivery possible. Because the product contains <0.3% delta-9 THC at sale, it meets hemp product definitions under the 2018 Farm Bill.

• Documentation: All packages include full COAs and receipts for customs
• Responsibility: You verify legality in your jurisdiction and accept customs/legal risk
• Contact: (832) 416-2816 or [email protected]

For Gilpin County residents who travel internationally or have family abroad needing access, this is revolutionary. Rick Simpson couldn’t ship his oil anywhere—it was Schedule I. A cancer patient in Canada or chronic pain sufferer in Europe can now access the same clinical-strength formula you can order from your mountain home.

How Our Formulas Connect to Scientific Evidence

Every cannabinoid in our formula—CBD, CBG, delta-8 THC, THCa, delta-9 THC, CBN, CBC—has an evidence profile in GENERAL KNOWLEDGE. Every terpene—limonene, myrcene, caryophyllene, pinene, linalool, humulene, terpinolene—is covered with preclinical and review-level evidence.

Our published formulas are anchored to per-compound evidence summaries explaining what is well-supported by human clinical data, what is emerging, and what is overstated. We don’t exempt ourselves from the same evidence standards applied to the broader field.

As Colin said in 2019: “I’m not trying to sell people snake oil… There’s enough research out there that people just need to know and try and have the best possible version to base their opinions off of to give it a fair shot.”

This guide is that research foundation.

Media Recognition: Seven ABC13 Features

September 15, 2019: Texas CBD Businesses Booming

Colin’s foundational quote: “I’m not trying to sell people snake oil. I’m not trying to sell people hope, but there’s enough research out there that people just need to know and try and have the best possible version to base their opinions off of to give it a fair shot as to whether it’s right or wrong for them.”

This 2019 quote is the seed of everything OilWell became. It established the principle of evidence-based honesty that differentiates us from every hype-driven competitor.

March 22, 2021: Entrepreneur Creates Direct-to-Consumer Business

Colin’s therapy quote: “Pain comes in a lot of different forms.” This went deeper than prior interviews, positioning OilWell at the intersection of Texas innovation and federal decriminalization momentum.

May 24, 2021: What is Delta-8 THC

Colin’s iconic exchange with Steve Campion:
Campion: “Why would someone want to smoke that?”
Colin: “I don’t give a sh** if it’s wrong to say you’ll get high off it. Maybe you want to get high.”

This radical honesty on mainstream TV—expletive preserved by the network—balanced with medical caution from UTHealth’s Dr. Weaver and regulatory advocacy from Heather Fazio. The DEA statement documented federal ambiguity that allowed the market to exist.

August 20, 2021: Houston CBD Shop Giving Away Free Products for COVID Vaccine

OilWell gave away 1,000 special edition caviar pre-rolls (valued at ~$35,000) to encourage COVID vaccination. Hosted at HydroShack Hydroponics, coordinated with the city of Houston, with no political agenda. This documented community action demonstrates our values in practice.

October 19, 2021: Texas Ban Over Delta-8

When Texas DSHS classified Delta-8 as Schedule I overnight, Colin proactively removed all products before enforcement and tried to warn other operators who were unknowingly shipping Schedule I narcotics. This ethical crisis leadership—absorbing major revenue loss to protect customers and industry—defines our character.

October 7, 2022: Biden Marijuana Pardon

The article revealed Colin’s personal marijuana conviction history: “You face challenges with housing, loans, and banking, I mean with about everything.” This transforms the entire media record—every quote carries additional weight knowing the speaker has personally experienced cannabis criminalization consequences.

April 21, 2023: Marijuana Industry Getting Creative

Colin’s “Renaissance” framing: “Right now is actually a pretty – like Renaissance – pretty important time that should be enjoyed now.” This positions OilWell at the frontier of an emerging market, completing a four-year media arc from local wholesaler to industry leader.

The Through-Line: What Seven Years of Media Coverage Reveals

Consistency: Colin appeared across seven features from 2019-2023, through every industry shift—CBD boom, Delta-8 rise and fall, COVID crisis, presidential pardons, state legislative debates. ABC13 repeatedly returned to him as primary source.

Breadth: Coverage spanned business, law, medicine, community health, politics. No other Houston figure spoke to that range.

Community Action: $35,000 in free product for vaccination, proactive Delta-8 removal, warning competitors—these are documented actions, not marketing claims.

Personal Stakes: The conviction revelation shows Colin isn’t an outside entrepreneur. He lived the consequences and built a legal business with integrity.

Evolution: From “local wholesaler” (2019) to “industry authority” (2023), the media record tracks both business growth and founder development.

This recognition cannot be purchased—only earned.

General Knowledge: The Science Behind Our Formulas

Research Method and Evidence Weighting

We prioritize: human clinical evidence → systematic reviews/meta-analyses → NIH/institutional summaries → preclinical literature when human data are sparse. This matters because the evidence base is uneven. CBD and delta-9 THC have strongest human data; delta-8 THC, THCa, CBG, CBN, CBC, and most terpenes rely more on reviews, animal work, and in vitro pharmacology [1]-[29].

NIH Institutional Baseline

• Best Supported: Rare epilepsies (CBD), chemo nausea/vomiting, HIV/AIDS appetite/weight loss [1].
• Modest Evidence: Chronic pain, MS-related symptoms [1].
• Not Approved: FDA has not approved cannabis plant itself for medical use [1].
• Safety Concerns: Impairment, motor vehicle crash risk, cannabis use disorder, pregnancy concerns, accidental pediatric exposure, contamination, THC-vape lung injury [1].
• CBD-Specific: Over-the-counter products may differ from labels. CBD associated with decreased alertness, GI effects, liver abnormalities, drug interactions [1].

Cannabinoid Evidence Profiles

CBD:

• Strongest Evidence: Seizure disorders—most credible human data [1][2].
• Anxiety: 2024 systematic review/meta-analysis of 316 participants showed significant anxiolytic signal but stressed limited clinical sample needs more trials [3].
• Pain: 2024 systematic review found promising but heterogeneous literature, with trial quality limiting confidence [4].
• Sleep: 2023 insomnia review found methodologically weak studies with few objective assessments [5].
• Safety: 2023 systematic review/meta-analysis found real signal for liver enzyme elevation and possible drug-induced liver injury, especially relevant for concentrated oral products and polypharmacy [6].
• Bottom Line: Most evidence-developed nonintoxicating cannabinoid, but strong evidence concentrated in few indications, not broad wellness claims [1]-[6].

CBG:

• Profile: Mostly review/preclinical; human evidence sparse [7][8].
• Pharmacology: Biosynthetic precursor with distinct receptor interactions (CB1, CB2, alpha-2 adrenoceptors, 5-HT1A) making it mechanistically interesting but not clinically established [7].
• Research Areas: Neurologic disorders, inflammatory bowel disease, antibacterial activity—primarily pharmacology-led hypotheses [7][8].
• Caution: Commercially sold while evidence base remains thin; claims often outrun science [7].
• Bottom Line: Promising minor cannabinoid with limited clinical validation [7][8].

Delta-8 THC:

• Profile: Pharmacologically relevant, psychoactive, much less clinically characterized than delta-9 THC [9]-[11].
• Pharmacology: 2022 review concluded delta-8 and delta-9 have broadly similar PK/PD behavior. Delta-8 is partial CB1 agonist, less potent than delta-9, likely due to weaker CB1 affinity [9].
• Public Health: 2023 scoping review found evidence base dominated by animal studies, chemistry, use reports, and safety concerns rather than strong human trials. Noted adverse consequences and regulatory/product-quality concerns [10].
• Manufacturing: Commercial interest tied to greater stability and easier synthesis relative to naturally scarce plant levels; product byproducts and lab-testing questions matter [11].
• Bottom Line: Psychoactive THC analogue with real pharmacologic activity, incomplete human safety characterization, more manufacturing-quality uncertainty than consumers realize [9]-[11].

THCa:

• Profile: Important chemically/formulation-wise, low on direct human therapeutic evidence [12].
• What It Is: Acidic precursor to THC; may represent large share of THC-related content in raw plant material. Decarboxylates to THC during heating/storage/processing [12].
• Psychoactivity: Does not produce THC’s psychoactive effects IF it stays acidic and isn’t substantially decarboxylated [12].
• Research: In vitro/rodent literature suggests anti-inflammatory, immunomodulatory, neuroprotective, antineoplastic possibilities—not equivalent to established human outcomes [12].
• Bottom Line: Highly relevant precursor molecule whose interpretation depends heavily on route, temperature, processing, storage. Any claim must account for possible conversion to THC [12].

Delta-9 THC:

• Profile: Strongest human evidence of psychoactive cannabinoids listed, clearest adverse-effect burden [1][13]-[15].
• Institutionally Supported: NCCIH identifies relevance to chemo nausea/vomiting, HIV/AIDS appetite/weight loss, some MS/pain outcomes—while stressing many other uses remain uncertain [1].
• Pain Evidence: 2022 systematic review of cannabis-based products for chronic pain found high-THC or comparable THC:CBD ratio products may provide short-term benefit but increase dizziness, sedation, nausea, discontinuation due to adverse events [13].
• Pharmacokinetics: Inhaled THC: seconds-minutes onset, peaks ~15-30 minutes, tapers over few hours. Oral THC: later onset, later peak, longer duration—matters for benefit and overconsumption risk [14].
• Mental Health Risk: 2025 systematic review of high-concentration THC products found consistent unfavorable associations with psychosis/schizophrenia outcomes and cannabis use disorder, plus concerning signals for anxiety/depression in nontherapeutic settings [15].
• Broader Safety: Anxiety/panic at high doses, tachycardia, blood pressure changes, dependency potential, withdrawal, pregnancy concerns, accidental pediatric exposure, vape-related lung injury [1][14][15].
• Bottom Line: Legitimate therapeutic relevance in some settings, but clearest intoxication, psychiatric, and dose-related safety liabilities in this document [1][13]-[15].

CBN:

• Profile: Weak human evidence; marketing ahead of data [12][16][17].
• Marketing Claims: Sleep and sedation—reputation widespread, clinical support far thinner [16][17].
• Sleep Evidence: 2021 narrative review screened 99 human-study abstracts, reviewed 8 full-text articles, found NO clinical trials using validated sleep questionnaires or polysomnography to substantiate strong sleep-promoting claims [16].
• Broader Sleep Literature: 2024 updated review concluded cannabinoid sleep research doesn’t match real-world use scale; need for better-designed, adequately powered trials remains substantial [17].
• Chemical Context: THC can degrade toward CBN under certain conditions, explaining why CBN is discussed in aging/oxidized cannabis contexts [12].
• Bottom Line: Clearest example where cultural reputation is stronger than current clinical evidence base [16][17].

CBC:

• Profile: Emerging, intriguing, overwhelmingly preclinical/review-based [18][19].
• Pharmacology: 2024 focused review argues CBC has distinct PK/PD and receptor behavior, highlighting antinociceptive, antibacterial, anti-seizure areas as interesting targets [18].
• Older Literature: Anti-inflammatory effects, reduced gut hypermobility, modest rodent analgesia, possible neurobiological/antiproliferative relevance—not strong patient-facing evidence [19].
• Safety Caution: 2024 CBC review notes over-the-counter products sold despite little evidence establishing clinical efficacy or safety [18].
• Bottom Line: Scientifically credible minor cannabinoid deserving more research, not yet validated clinical active [18][19].

Terpene Evidence Profiles

Important Note: Terpene claims need stricter interpretation than cannabinoid claims. Much literature comes from isolated compounds, essential oils, non-cannabis plants, or preclinical models rather than controlled human studies of cannabis formulations. Robust proof of clinically meaningful entourage effects in humans remains limited [20][29].

Limonene:

• Profile: Largely review/preclinical, useful safety literature [20]-[22].
• Potential Activity: 2021 review describes multifunctional monoterpene with antioxidant, anti-inflammatory, cardioprotective, gastroprotective, immune-modulatory possibilities—overwhelmingly from nonhuman/non-cannabis literature [21].
• Safety: Oxidation products (hydroperoxides) are clinically relevant contact allergens important in patch-testing [22].
• Bottom Line: Biologically active, widely discussed, but cannabis-specific therapeutic claims should stay conservative without direct human support [20]-[22].

Myrcene:

• Profile: Mostly preclinical, very limited human evidence [20][23].
• Research: 2021 review describes anxiolytic, antioxidant, anti-inflammatory, analgesic properties, discusses mechanisms, but explicitly states human studies lacking [23].
• Interpretation Caution: Often invoked as proven sedative explaining “couch-lock”—stronger claim than human evidence supports [20][23].
• Bottom Line: Plausible bioactive terpene, but compound-specific clinical claims about mood, pain, sedation remain far ahead of definitive human proof [23].

Caryophyllene:

• Profile: Among most mechanistically interesting due to direct cannabinoid-system relevance, but still mostly preclinical [24].
• Why It Stands Out: 2021 focused review describes beta-caryophyllene as selective CB2 receptor agonist—unusual, making it especially relevant pharmacologically rather than purely aromatic [24].
• Research Themes: Anti-inflammatory, immunomodulatory, antioxidant, neuroprotective, gastroprotective—human clinical confirmation limited [24].
• Bottom Line: Strongest candidate for terpene with cannabinoid-system significance, but should not be described as clinically proven for commonly attributed outcomes [24].

Pinene:

• Profile: Promising preclinical literature, weak human confirmation [20][25].
• Brain-Health Framing: 2021 review found antioxidant, anti-inflammatory, neuroprotective signals justifying future study, but emphasized evidence is mostly preclinical and well-designed clinical trials lacking [25].
• Interpretation Caution: Claims that pinene reliably improves memory, sharpens attention, or counterbalances THC cognitive effects remain interesting hypotheses, not settled clinical facts [20][25].
• Bottom Line: Deserves scientific attention, but strong cognition-related claims should be presented as exploratory [25].

Linalool:

• Profile: Substantial preclinical interest, limited direct human confirmation [20][22][25][26].
• Research: Repeatedly discussed for stress, mood, brain-health pharmacology. 2021 brain-health review found enough preclinical signal to justify continued investigation while emphasizing lack of robust human trials [25].
• Additional Literature: Separate reviews discuss possible antidepressant mechanisms, but remains translational rather than definitive clinical story [26].
• Safety: Oxidized linalool hydroperoxides recognized allergens in dermatitis literature [22].
• Bottom Line: Scientifically credible bioactive terpene, but current evidence supports cautious phrasing rather than firm therapeutic promises [22][25][26].

Humulene:

• Profile: Translationally interesting, still early [20][27].
• Scoping Review: 2024 review analyzed 340 articles, found broad preclinical evidence for anti-inflammatory effects, some rodent work suggesting cannabimimetic properties via CB1 and adenosine A2a pathways—valuable for hypothesis generation but not established human efficacy [27].
• Bottom Line: More interesting research target than some terpenes, but far from clinically settled [27].

Terpinolene:

• Profile: Least clinically characterized terpene in this file [20][28].
• Systematic Review: 2021 review screened 2,449 records, included 57 studies, concluded range of reported biological effects but evidence base still dominated by in silico, in vitro, animal studies rather than human trials [28].
• Bottom Line: Biologically interesting, but especially underdeveloped clinically [20][28].

Research Limits and Interpretation

• Uneven Evidence Base: CBD and delta-9 THC support most detailed human-facing statements; others require more caution [1]-[29].
• Data Categories Not Interchangeable: Whole-cannabis extract, purified molecule, semisynthetic cannabinoid, and terpene-only data are distinct. Common error is letting evidence from one category stand in for another.
• Minor Cannabinoids Commercially Interesting Because Underexplored: This also means claims around them often become inflated.
• Product Quality Matters: Labeling inaccuracies, contamination, synthesis byproducts, dose variability, route-dependent PK all materially affect real-world interpretation [1][10][11][14].
• THCa Chemistry Changes: Storage and heating convert acidic cannabinoids to neutral forms like THC [12].

Common Overstatements to Avoid (And What to Say Instead)

• Overstatement: CBN is clinically proven sleep cannabinoid.
  Accurate: Specific sleep evidence for CBN remains weak and dated, with no strong validated-trial base [16][17].

• Overstatement: Myrcene is proven human sedative causing couch-lock.
  Accurate: Myrcene has plausible preclinical bioactivity, but direct human proof for common claim is limited [20][23].

• Overstatement: Terpenes have proven entourage effects in patients.
  Accurate: Entourage hypotheses are influential and worth studying, but robust clinical proof remains limited and highly compound-specific [20][29].

• Overstatement: THCa is always non-psychoactive.
  Accurate: THCa itself isn’t THC, but heating/processing can convert THCa to THC, changing effective exposure [12].

• Overstatement: Delta-8 THC is safe because hemp-derived.
  Accurate: Delta-8 THC is psychoactive, pharmacologically close to delta-9 THC, and often entangled with manufacturing/testing concerns [9]-[11].

Practical Takeaways for Our Formulas

• Most Evidence-Developed: CBD and delta-9 THC.
• Delta-8 THC: Not trivial or purely mild; psychoactive cannabinoid with less robust safety/efficacy characterization than delta-9 THC.
• THCa: Meaningfully changes with processing; don’t interpret raw, gently-handled, and heated formats the same.
• CBG, CBN, CBC: Scientifically credible but clinically immature compared to CBD/THC.
• Terpenes: Highly relevant to aroma/flavor, potentially some bioactivity, but compound-specific human therapeutic claims should be careful and only where directly supported.

RSO Sublingual Oil Formula: The Complete Breakdown

Cannabinoid	Amount
CBD	4,500mg
CBG	3,000mg
Delta-8 THC	6,000mg
THCa	1,500mg
Delta-9 THC	90mg
CBN	750mg
CBC	750mg
Total Cannabinoids	16,590mg

• Live Terpenes: 5% (limonene, myrcene, caryophyllene, pinene, linalool, humulene, terpinolene)
• Volume: 30mL (1 fl oz)
• Carrier: Organic MCT oil
• Concentration: 553mg active cannabinoids per mL
• Dosing: Graduated dropper with 0.1mL precision

For Gilpin County DIY makers, this table is your recipe. Source individual cannabinoid distillates and isolates, blend at these ratios, and you’ll create a functionally identical product. We publish this because accessibility matters more than profit protection.

RSO Vape Cartridge Formula

Cannabinoid	Percentage
CBD	30%
CBG	20%
Delta-8 THC	15%
THCa	10%
CBN	10%
CBC	10%

• Live Terpenes: 5%+
• Volume: 1-gram cartridge
• Compatibility: 510-thread universal battery
• Feature: Automatic THCa decarboxylation at vaping temperature (400-450°F)

For Gilpin County residents needing acute relief—whether breakthrough pain during a mountain hike or sudden panic attack—this format delivers effects in 1-2 minutes, unmatched by any oral product.

Terpene Profile (Both Products)

• Limonene: Citrus-bright aroma, mood support potential
• Myrcene: Earthy base, relaxation associations
• Caryophyllene (β-caryophyllene): Pepper/spice scent, CB2 receptor interaction
• Pinene: Forest-fresh aroma, clarity associations
• Linalool: Floral, lavender notes, calming potential
• Humulene: Earthy, woody scent, anti-inflammatory research
• Terpinolene: Piney, fruity, sparkling complexity

This profile was designed to complement the cannabinoid formula: limonene for mood, myrcene for relaxation, caryophyllene for CB2 activation, pinene for clarity, linalool for calm, humulene for inflammation, terpinolene for sensory complexity. For Gilpin County residents familiar with mountain forest aromas and herbal remedies, these terpenes connect the product experience to your natural environment.

How to Order RSO in Gilpin County

Online Ordering:
Visit OilWellCBD.com and navigate to our RSO Sublingual Oil or RSO Vape Cartridge product pages. Add to cart, checkout, and select shipping to Colorado. Orders typically arrive within 3-5 business days via USPS Priority Mail.

Phone Orders:
Call (832) 416-2816 Monday-Thursday 10 AM – 7 PM, Friday-Saturday 10 AM – 10 PM, Sunday 10 AM – 4 PM (Central Time). Our team can answer questions about dosing, decarboxylation, and which format fits your Gilpin County lifestyle.

Email:
[email protected] for custom formulation requests, bulk orders, or international shipping inquiries.

Instagram:
@oilwellcbd for product updates, educational content, and community stories.

Final Thoughts for Gilpin County

We wrote this guide because you deserve complete transparency. In a small mountain community where word-of-mouth travels fast and trust is earned through honesty, we believe education beats hype every time.

Whether you’re dealing with chronic pain from years of physical labor, supporting a loved one through cancer treatment, managing PTSD from military service, or simply exploring cannabis science, our commitment is the same: provide the best possible version of the information so you can give it a fair shot and decide if it’s right or wrong for you.

OilWell Cannabis is more than a brand—it’s a promise to deliver the most thoughtful cannabis products available, rooted in the mission that started when Bentley got up, walked across the room, and brought his ball to play. That miracle of cannabinoid medicine drives everything we do.

From our Houston base to your home in Gilpin County, we’re here to provide not just products, but partnership in your wellness journey. The mountains teach resilience; we provide the tools to help your body and mind match that strength.

Order today and experience the difference that evidence-informed, patient-controlled, open-source RSO can make.